Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
March 09, 2022The blockbuster drug that wasn't18 minutesPlayThe FDA green light for aducanumab for Alzheimer’s disease raised dozens of red flags. Will it be approved here? Hosted on Acast. See acast.com/privacy for more information....moreShareView all episodesBy The Medical RepublicMarch 09, 2022The blockbuster drug that wasn't18 minutesPlayThe FDA green light for aducanumab for Alzheimer’s disease raised dozens of red flags. Will it be approved here? Hosted on Acast. See acast.com/privacy for more information....moreMore shows like The Tea RoomView allLong Covid Podcast70 Listeners
The FDA green light for aducanumab for Alzheimer’s disease raised dozens of red flags. Will it be approved here? Hosted on Acast. See acast.com/privacy for more information.
March 09, 2022The blockbuster drug that wasn't18 minutesPlayThe FDA green light for aducanumab for Alzheimer’s disease raised dozens of red flags. Will it be approved here? Hosted on Acast. See acast.com/privacy for more information....more
The FDA green light for aducanumab for Alzheimer’s disease raised dozens of red flags. Will it be approved here? Hosted on Acast. See acast.com/privacy for more information.